The digital future beyond the pill

A recent story in the FT has the title  Digital disrupters take big pharma ‘beyond the pill’ It gives a distinctive twist to the idea of digital drugs. The argument is that a phone app or similar, as a monitoring device and as a front end to diverse networked resources including counselling, can be  a direct substitute for a […]

Brexit and the Falsified Medicines Directive

In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with […]

Warfarin: Testing at Home

Here is the second in our series of short films on aspects of warfarin.

Warfarin is the chief oral anticoagulant of its kind in use in the UK and is used by 1% of the UK population approximately 600,000 people and by 6% of people over 80. Testing at home is revolutionizing the care of patients as they can test […]

Map Your Medicines!

Open Platform event, at the Wellcome Collection, London

The D3 team would like to invite you to an Open Platform event at the Wellcome Collection, Euston Rd, London on Tuesday 18th October at 2pm.

We will be asking: How do medicines fit into our lives? How do we get them and what do we do with them?
Join us in the Reading Room to discuss […]

  • Permalink Gallery

    Hub and Spoke Dispensing: Safety and Sociotechnical Pliability

Hub and Spoke Dispensing: Safety and Sociotechnical Pliability

Over the course of the last year, the Department of Health has looked at the use of hub and spoke dispensing systems for community pharmacy in England, a technology which some view as an inevitable extension of electronic prescription transmission in primary care. In a hub and spoke system, medicines required for a primary care prescription are put together […]

  • Permalink Gallery

    Error in algorithm to assess risk (and inform prescription of statins)

Error in algorithm to assess risk (and inform prescription of statins)

Computer error may have led to incorrect prescribing of statins to thousands of patients

BMJ 2016;353:i2742

Thousands of patients in England may have been incorrectly prescribed or taken off statins because of a major IT glitch.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has launched an investigation after a fault was discovered with the digital QRISK2 calculator in SystmOne, run by […]

  • Permalink Gallery

    ‘the little liar’ – patient information about medicines

‘the little liar’ – patient information about medicines

There is an Italian expression used especially in Tuscany that refers to the Patient Information Leaflet (PIL) as ‘il bugiardino’. It translates as ‘the little liar’.

L’Accademia della Crusca explains how the adjective ‘liar’ (bugiardo) can be used only for a person, as only people can conceive and tell lies, but that in this case it refers to an inanimate […]

May 10th, 2016|Medicines|0 Comments|

Old drugs for new uses

Researchers at the University of Leeds are using: the anti-psychotic haloperidol; the anti-depressant fluoxetine and a local anaesthetic bupivacainein as anti-virals.

The drugs disrupt the regulation of potassium levels and this, in turn, blocks the ability of all of the group of bunyaviruses to infect cells. It’s not effective on all viruses, but is looking very promising research.

Full article here.

The development of oral anticoagulants

Nature have released a short (5 min approx.) video on the development of oral anticoagulants. It is beautifully produced and informative.

March 3rd, 2016|Medicines|0 Comments|

Network Analysis of Instagram data on medicines use

Research shows how data on social network (Instagram) have great potential for public health monitoring and surveillance for adverse drug reactions and drug-drug interactions.

Correia, Rion Brattig, Lang Li, and Luis M. Rocha. “Monitoring Potential Drug Interactions and Reactions via Network Analysis of Instagram User Timelines.” Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing. Vol. 21. NIH Public Access, 2016.